Alina S. Dzharullaeva
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Identification of novel 5' UTR variants for enhanced mRNA translation and vaccine immunogenicity.
Journal: Scientific reports
Published: March 09, 2026
Structural Design of T-Cell Epitope-Based mRNA Vaccine Constructs Determines the Quality of T-Cell Immunity and Protective Efficacy Against SARS-CoV-2 in Mice.
Journal: Vaccines
Published: February 13, 2026
Broadly neutralizing single-domain antibody targeting the spike NTD displays therapeutic efficacy against diverse SARS-CoV-2 variants.
Journal: Frontiers in immunology
Published: January 29, 2026
Dual Ionizable Lipids (ALC0315 and SM102) in a Novel Lipid Nanoparticle Formulation Enhance In Vivo Delivery and Time-Dependent Expression of Messenger RNA and Self-Amplifying RNA.
Journal: ChemMedChem
Published: January 28, 2026
Novel Multistage Subunit Mycobacterium tuberculosis Nanoparticle Vaccine Confers Protection Against Experimental Infection in Prophylactic and Therapeutic Regimens.
Journal: Vaccines
Published: November 05, 2025
Sputnik V update: safety and neutralizing antibodies in healthy adults and adolescents.
Journal: Frontiers in immunology
Published: October 31, 2025
Circular mRNA against CleanCap linear mRNA vectors: comprehensive comparison, expression, active and passive immunization.
Journal: Frontiers in immunology
Published: October 29, 2025
Immunization route-mediated differences in long-term maturation of humoral immune response induced by adenovirus vector-based COVID-19 vaccine Sputnik V in nonhuman primates.
Journal: Frontiers in immunology
Published: May 23, 2025
Molecular Biomarkers of Neurodegeneration in Amyotrophic Lateral Sclerosis.
Journal: Biochemistry. Biokhimiia
Published: April 20, 2025
The Parameters of Long-Term Humoral Immunity Induced by a Single Injection of the Sputnik Light Vaccine Among Noninfected Volunteers and Those Infected with SARS-CoV-2.
Journal: Acta naturae
Published: September 16, 2024
Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia.
Journal: Frontiers in immunology
Published: August 27, 2024
Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5.
Journal: Vaccines
Published: August 21, 2024
Last Updated: 09/26/2026